A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dacemazine | Dacemazine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: dacemazine;10-(Dimethylamino)acetyl-10H-phenothiazine;10-(N,N-Dimethylglycyl)-10H-phenothiazine;10-[(Dimethylamino)acetyl]-10H-phenothiazine;Ahistan;Histantin Richter);2-(dimethylamino)-1-phenothiazin-10-ylethanone;2-(dimethylamino)-1-phenothiazin-10-yl-. Product Category: Heterocyclic Organic Compound. CAS No. 518-61-6. Molecular formula: C16H16N2OS. Mole weight: 284.381. Density: 1.246g/cm³. Product ID: ACM518616. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Dacetuzmumab | Cas No. 880486-59-9. |  |
| Dacetuzumab | Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 880486-59-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99015. |  |
| Dacinostat | Dacinostat, also known as LAQ824, is a hydroxamate histone deacetylase inhibitor with potential anticancer activity. LAQ824 sensitized nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. LAQ824 reduced clonogenic survival of the H23 and H460 cell lines five-fold compared with controls and four-fold compared with either agent alone (P<0.001). In phase I trials, LAQ824 was well tolerated at doses that induced accumulation of histone acetylation, with higher doses inducing changes consistent with HSP90 inhibition. Synonyms: NVP-LAQ824; NVP LAQ824; LAQ-824; LAQ824; LAQ 824; Dacinostat. CAS No. 404951-53-7. Molecular formula: C22H25N3O3. Mole weight: 379.46. | |
| Dacitracin | Dacitracin. CAS No. 1405-87-4. Product ID: 8-01443. Molecular formula: C63H98N14O14S. Mole weight: 1307.62. |  |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grades: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. | |
| Daclatasvir | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052; EBP 883. CAS No. 1009119-64-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10466. | |
| Daclatasvir | Daclatasvir. Group: Biochemicals. Grades: Highly Purified. CAS No. 1009119-64-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. |  Worldwide |
| Daclatasvir Diethyl Ester-d10 | Daclatasvir Diethyl Ester-d10 is the isotope labelled analog of Daclatasvir Diethyl Ester (D101525); an impurity of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H44D10N8O6, Molecular Weight: 776.99. US Biological Life Sciences. | Worldwide |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grades: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6·2HCl. Mole weight: 811.8. | |
| Daclatasvir dihydrochloride | Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052 dihydrochloride; EBP 883 dihydrochloride. CAS No. 1009119-65-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10465. | |
| Daclatasvir Impurity 1 | Daclatasvir Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2698401-11-3. Molecular Formula: C40H51ClN8O6. Mole Weight: 775.35. Catalog: APB2698401113. |  |
| Daclatasvir Impurity 10 | Daclatasvir Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009119-83-8. Molecular Formula: C26H29ClN6. Mole Weight: 461.01. Catalog: APB1009119838. | |
| Daclatasvir Impurity 11 | Daclatasvir Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007882-23-6. Molecular Formula: C36H44N6O4. Mole Weight: 624.79. Catalog: APB1007882236. | |
| Daclatasvir Impurity 1 (RSSS-Isomer) | Daclatasvir Impurity 1 (RSSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: dimethyl ((2S,2'R)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate. CAS No. 1417333-83-5. Molecular Formula: C40H50N8O6. Mole Weight: 738.88. Catalog: APB1417333835. | |
| Daclatasvir Impurity 1 (SRSS-Isomer) | Daclatasvir Impurity 1 (SRSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Daclatasvir Impurity 1 (SRSS-Isomer). CAS No. 1009117-28-5. Molecular Formula: C40H50N8O6. Mole Weight: 738.88. Catalog: APB1009117285. | |
| Daclatasvir Impurity 3 | Daclatasvir Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2226822-77-9. Molecular Formula: C40H51ClN8O6. Mole Weight: 775.35. Catalog: APB2226822779. | |
| Daclatasvir Impurity 4 | Daclatasvir Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009117-26-3. Molecular Formula: C40H50N8O6. Mole Weight: 738.89. Catalog: APB1009117263. | |
| Daclatasvir Impurity 4 | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir RSSR Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 5 | Daclatasvir Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009107-27-0. Molecular Formula: C40H50N8O6. Mole Weight: 738.89. Catalog: APB1009107270. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 6 | Daclatasvir Impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2077207-88-4. Molecular Formula: C41H52N8O6. Mole Weight: 752.92. Catalog: APB2077207884. | |
| Daclatasvir Impurity 7 | Daclatasvir Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C40H49N7O7. Mole Weight: 739.87. Catalog: APB12391. | |
| Daclatasvir Impurity 8 | Daclatasvir Impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2226541-13-3. Molecular Formula: C35H41N7O4. Mole Weight: 623.76. Catalog: APB2226541133. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007884-60-7. Molecular Formula: C33H39N7O3. Mole Weight: 581.72. Catalog: APB1007884607. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Daclizumab | Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. | |
| DACM | DACM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N-(7-Dimethylamino-4-methylcoumarin-3-yl)maleimide. Product Category: Other Fluorophores. Appearance: Orange solid. CAS No. 55145-14-7. Molecular formula: C16H14N2O4. Mole weight: 298.29. Purity: 98%+. IUPACName: 1-[7-(dimethylamino)-4-methyl-2-oxochromen-3-yl]pyrrole-2,5-dione. Canonical SMILES: CC1=C(C(=O)OC2=C1C=CC(=C2)N(C)C)N3C(=O)C=CC3=O. Product ID: ACM55145147-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide, Dachshund. | |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm) [1]. Uses: Scientific research. Group: Fluorescent dye. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC 50 s of 6 nM, 45.7 nM and 73.7 nM for EGFR , ERBB2 , and ERBB4 , respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib hydrate | Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan- ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804 hydrate; PF-299804 hydrate. CAS No. 1042385-75-0. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-118263. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 1 | Dacomitinib Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C8H3FN4O5. Mole Weight: 254.13. Catalog: APB12399. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2106-05-0. Molecular Formula: C6H5ClFN. Mole Weight: 145.56. Catalog: APB2106050. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3,4-difluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25F2N5O2. Mole Weight: 453.48. Catalog: APB05285. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13991-36-1. Molecular Formula: C4H5BrO2. Mole Weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((4-chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05284. | |
| Dacomitinib Impurity 12 | Dacomitinib Impurity 12. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05283. | |
| Dacomitinib Impurity 13 | Dacomitinib Impurity 13. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C23H22ClF2N5O. Mole Weight: 457.9. Catalog: APB05281. | |
| Dacomitinib Impurity 14 | Dacomitinib Impurity 14. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C26H32ClFN6O2. Mole Weight: 515.03. Catalog: APB12400. | |
| Dacomitinib Impurity 15 | Dacomitinib Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(5-cyano-4-((E)-((dimethylamino)methylene)amino)-2-methoxyphenyl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C20H27N5O2. Mole Weight: 369.46. Catalog: APB05282. | |
| Dacomitinib Impurity 16 | Dacomitinib Impurity 16. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H26FN5O2. Mole Weight: 435.49. Catalog: APB05280. | |
| Dacomitinib Impurity 17 | Dacomitinib Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H26ClN5O2. Mole Weight: 451.95. Catalog: APB05279. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C8H4N4O6. Mole Weight: 252.14. Catalog: APB12398. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-chloro-1-fluoro-4-nitrobenzene. CAS No. 350-30-1. Molecular Formula: C6H3ClFNO2. Mole Weight: 175.54. Catalog: APB350301. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3 | Dacomitinib Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2250242-14-7. Molecular Formula: C8H4N4O6. Mole Weight: 252.14. Catalog: APB2250242147. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity 4 | Dacomitinib Impurity 4. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-(piperidin-1-yl)pyrrolidin-2-one. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05290. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one. CAS No. 2190490-31-2. Molecular Formula: C19H16ClFN4O3. Mole Weight: 402.81. Catalog: APB2190490312. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 53449-14-2. Molecular Formula: C8H4ClN3O3. Mole Weight: 225.59. Catalog: APB53449142. | |
| Dacomitinib Impurity 6 | Dacomitinib Impurity 6. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 5-((3-chloro-4-fluorophenyl)amino)-1-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)pyrrolidin-2-one. Molecular Formula: C25H20Cl2FN5O2. Mole Weight: 512.36. Catalog: APB05288. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(3-(3-chloro-4-fluorophenyl)-4-imino-7-methoxy-3,4-dihydroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05289. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2168856-93-5. Molecular Formula: C7H5FN2O4. Mole Weight: 200.13. Catalog: APB2168856935. | |
| Dacomitinib Impurity 8 | Dacomitinib Impurity 8. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-(N-(3-chloro-4-fluorophenyl)acetamido)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C26H27ClFN5O3. Mole Weight: 511.98. Catalog: APB05286. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide. Molecular Formula: C19H16ClFN4O2. Mole Weight: 386.81. Catalog: APB05287. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grades: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity SF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25F2N5O2. Mole weight: 453.49. | |
| Dacomitinib Impurity SFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: Dacomitinib Impurity SFAJ; CS-0255393; F83329; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine; N4-(3,4-DIFLUOROPHENYL)-7-METHOXY-QUINAZOLINE-4,6-DIAMINE; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity). Grades: ≥95%. CAS No. 2117703-26-9. Molecular formula: C15H12F2N4O. Mole weight: 302.28. | |
| Dacomitinib Impurity SFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2119689-75-5. Molecular formula: C15H10F2N4O3. Mole weight: 332.26. | |
| Dacomitinib Impurity SL | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25Cl2N5O2. Mole weight: 486.40. | |
Our database is helping our users find suppliers everyday.
